Tratamento de Escabiose com Ivermectina em Crianças com Menos de 15 kg: Uma Opção Segura e Eficaz

António Magarreiro-Silva; José Alberto Ramos; Hugo Leme; Joana Margarida Reis; Rita Pimenta

doi:10.20344/amp.23219

Treatment of Scabies Using Ivermectin in Children Under 15 kg: A Safe and Effective Option

Authors

António Magarreiro-Silva Serviço de Dermatovenereologia. Hospital Garcia de Orta. Unidade Local de Saúde Almada-Seixal. Almada. https://orcid.org/0000-0002-0433-0352
José Alberto Ramos Serviço de Dermatovenereologia. Hospital Garcia de Orta. Unidade Local de Saúde Almada-Seixal. Almada. https://orcid.org/0009-0007-5362-1141
Hugo Leme Serviço de Dermatovenereologia. Hospital Garcia de Orta. Unidade Local de Saúde Almada-Seixal. Almada. https://orcid.org/0009-0008-9011-2618
Joana Margarida Reis Serviço de Dermatovenereologia. Hospital Garcia de Orta. Unidade Local de Saúde Almada-Seixal. Almada.
Rita Pimenta Serviço de Dermatovenereologia. Hospital Garcia de Orta. Unidade Local de Saúde Almada-Seixal. Almada. https://orcid.org/0000-0001-6302-338X

DOI:

https://doi.org/10.20344/amp.23219

Keywords:

Child, Ivermectin/therapeutic use, Scabies/drug therapy

Abstract

n/a.

Downloads

Download data is not yet available.

References

Vieira SS, Bernardo D, Machado S. Abordagem da escabiose em idade pediátrica: uma atualização. Acta Med Port. 2025;38:175-81.

Morand A, Weill A, Miquel J, Chosidow O, Guillot B, Tannous J, et al. Management of scabies in children under 15kg and pregnant or breastfeeding women: recommendations supported by the Centre of Evidence of the French Society of Dermatology. Br J Dermatol. 2024;191:1014-6.

Agence Nationale de Sécurité du Médicament et des Produits de Santé. Notice patient: Ivermectin (MECTIZAN). [consultado 2025 mar 27]. Disponível em: https://agence-prd.ansm.sante.fr/php/ecodex/notice/N0342965.htm.

Jittamala P, Monteiro W, Smit MR, Pedrique B, Specht S, Chaccour CJ, et al. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? PLoS Negl Trop Dis. 2021;15:e0009144.

Wilkins AL, Steer AC, Cranswick N, Gwee A. Question 1: Is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? Arch Dis Child. 2018;103:514.1-9.

Gwee A, Steer A, Phongluxa K, Luangphaxay C, Senggnam K, Philavanh A, et al. Ivermectin therapy for young children with scabies infection: a multicentre phase 2 non-randomized trial. Lancet Reg Health West Pac. 2024;49:101144.

Downloads

PDF (Português)

Published

2025-10-01

How to Cite

Magarreiro-Silva A, Alberto Ramos J, Leme H, Reis JM, Pimenta R. Treatment of Scabies Using Ivermectin in Children Under 15 kg: A Safe and Effective Option. Acta Med Port [Internet]. 2025 Oct. 1 [cited 2025 Dec. 17];38(10):670-1. Available from: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/23219

Download Citation

Issue

Vol. 38 No. 10 (2025): October

Section

Letters to the Editor

License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.

It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.

Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.

After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.